Request Appointment
160 East 53rd StreetNew York, NY 10022
Overview of Dr. Raj
Dr. Nitya Raj is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from University of Michigan Medical School and has been in practice 16 years. She is one of 527 doctors at Memorial Sloan Kettering Cancer Center and one of 87 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. She has more than 50 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
Johns Hopkins UniversityResidency, Internal Medicine, 2010 - 2013
University of Michigan Medical SchoolClass of 2010
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 2020 - 2027
NY State Medical License 2013 - 2026
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2017
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2017
Clinical Trials
- Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC) Start of enrollment: 2017 Feb 14
- A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide Start of enrollment: 2017 Sep 19
- Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE Start of enrollment: 2021 Dec 21
Roles: Contact
Publications & Presentations
PubMed
- The Genomic Landscape of MYC, MYCL, and MYCN Amplified Solid Tumors.Matteo Repetto, Allison L Richards, Monica F Chen, Pier Selenica, Shalabh Suman
Clinical Cancer Research. 2026-06-24 - ACR Appropriateness Criteria® Staging and Follow-Up of Adrenal Cancer., Silvia D Chang, Cassandra Jeavons, Gary A Ulaner, Andrei S Purysko
Journal of the American College of Radiology. 2026-03-21 - 1 citationsAutomated Portal-Enabled Elicitation of Health-Related Patient Values in Solid Tumor Oncology: Feasibility and Patient Characteristics Associated With Patient Response.Andrew S Epstein, Andrea Knezevic, Afshana Hoque, William E Rosa, James J Harding
JCO Oncology Practice. 2026-03-01
Press Mentions
Navigating Rare Neuroendocrine Tumors: Dr. Nitya Raj on Treatment Resistance and Improving Care for PatientsJanuary 8th, 2025- Memorial Sloan Kettering Awards and AppointmentsOctober 16th, 2020
A Study of LEE011 with Everolimus in Patients with Advanced Neuroendocrine TumorsMarch 2nd, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
